XTX Topco’s Innoviva INVA Stock Holding History

XTX Topco’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,003	Closed	-$402K	–	3538
2025 Q3	$402K	Buy	+22,003	New	+$429K	0.02%	1260
2025 Q2	–	Sell	-65,117	Closed	-$1.18M	–	2746
2025 Q1	$1.18M	Buy	+65,117	New	+$1.17M	0.06%	464
2022 Q4	–	Sell	-11,161	Closed	-$130K	–	1309
2022 Q3	$130K	Sell	11,161 -563	-5%	-$7.72K	0.03%	892
2022 Q2	$173K	Buy	+11,724	New	+$192K	0.07%	503

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's INVA Position: Q4 2025 in Review

XTX Topco sold out of Innoviva (INVA) in Q4 2025, closing a stake of 22,003 shares — an estimated $402K sold.

XTX Topco first reported a position in INVA in Q2 2022 and held it in 4 quarters. The position peaked at $1.18M in Q1 2025. 280 funds tracked by Wall St. Rank hold INVA as of Q4 2025.

XTX Topco reported no remaining Innoviva position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 22,003 Innoviva shares in Q4 2025, an estimated $402K.
XTX Topco first reported a position in Innoviva in Q2 2022 and held it in 4 quarters.
XTX Topco's Innoviva position peaked at $1.18M in Q1 2025.
280 funds tracked by Wall St. Rank held Innoviva as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.